IP Library Granted Patent US 12,275,890
Granted Patent B2
US 12,275,890 · App. 18/503,023 · Granted Apr 15, 2025

Metal sulfide scale dissolver for oilfield application

Inventors: Alex Yi-Tsung Lu (Houston, TX); Zhiwei Yue (Houston, TX)
Assignee: Halliburton Energy Services, Inc.
C09K8/532E21B37/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,275,890
App. No.
18/503,023
Granted
Apr 15, 2025
Kind
B2
Abstract

A method may include providing a treatment fluid comprising a metal sulfide dissolver and a base fluid. The metal sulfide dissolver includes a chelating agent, a boosting agent, a scaling agent, and a dispersing agent. The treatment fluid is then injected to contact a metal sulfide scale, which dissolves at least partially. The treatment fluid may be injected into a wellbore as a standalone treatment or as an additive.

Claims (27)

1. A method comprising:

providing a treatment fluid comprising:

a metal sulfide dissolver comprising a chelating agent, a boosting agent, a scaling agent, and a dispersing agent,

wherein the chelating agent comprises tetrakis (hydroxymethyl) phosphonium sulfate (THPS), salts thereof, or combinations thereof in an amount of about 0.03 wt % to about 0.1 wt % by weight of the treatment fluid;

wherein the boosting agent comprises citric acid in an amount of about 0.02 wt % to about 0.07 wt % by weight of the treatment fluid;

wherein the scaling agent comprises diethylene triamine penta (methylene phosphonic acid) (DTPMP) in an amount of about 0.003 wt % to about 0.02 wt % by weight of the treatment fluid;

wherein the dispersing agent comprises polydiallyldimethylammonium chloride (polyDADMAC) in an amount of about 25 ppm to about 200 ppm by weight of the treatment fluid; and

a base fluid;

contacting a metal sulfide scale with the treatment fluid; and

dissolving from 67% to 97% of the metal sulfide scale with the treatment fluid.

2. The method of claim 1 , wherein the tetrakis (hydroxymethyl) phosphonium sulfate (THPS) is present in an amount of about 0.04 wt % to about 0.1 wt % by weight of the treatment fluid.

3. The method of claim 1 , wherein the citric acid is present in an amount of about 0.04 wt % to about 0.07 wt % by weight of the treatment fluid.

4. The method of claim 1 , wherein the polydiallylammonium chloride (polyDADMAC) is present in an amount of about 40 ppm to about 200 ppm by weight of the treatment fluid.

5. A method comprising:

preparing a treatment fluid comprising:

a metal sulfide dissolver comprising a chelating agent, a boosting agent, a scaling agent, and polydiallyldimethylammonium chloride (polyDADMAC),

wherein the chelating agent comprises tetrakis (hydroxymethyl) phosphonium sulfate (THPS), salts thereof, or combinations thereof in an amount of about 0.03 wt % to about 0.1 wt % by weight of the treatment fluid;

wherein the boosting agent comprises citric acid in an amount of about 0.02 wt % to about 0.07 wt % by weight of the treatment fluid;

wherein the scaling agent comprises diethylene triamine penta (methylene phosphonic acid) (DTPMP) in an amount of about 0.003 wt % to about 0.02 wt % by weight of the treatment fluid;

wherein the polydiallyldimethylammonium chloride (polyDADMAC) in present in an amount of about 25 ppm to about 200 ppm by weight of the treatment fluid; and

a base fluid;

introducing the treatment fluid into a wellbore; and

contacting sulfide scale with the treatment fluid to dissolve from 67% to 97% of the sulfide scale.

6. The method of claim 5 , wherein polydiallyldimethylammonium chloride (polyDADMAC) is present in an amount of about 40 ppm to about 200 ppm by weight of the treatment fluid.

7. The method of claim 5 , wherein the tetrakis (hydroxymethyl) phosphonium sulfate (THPS) is present in an amount of about 0.04 wt % to about 0.1 wt % by weight of the treatment fluid.

8. The method of claim 5 , wherein the citric acid is present in an amount of about 0.04 wt % to about 0.1 wt % by weight of the treatment fluid.

9. The method of claim 5 , wherein the base fluid comprises an aqueous fluid with a pH of about 6.8 to about 7.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2026
From: HALLIBURTON ENERGY SERVICES, INC.
To: STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED
Reel/Frame 075930/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2023
From: LU, ALEX YI-TSUNG; YUE, ZHIWEI
To: HALLIBURTON ENERGY SERVICES, INC.
Reel/Frame 065477/0944 →
Continuity (2)
Continuation In Part 18241021 · Aug 31, 2023
Related Publication 20250075120A1 · Mar 6, 2025
References Cited (24)
US 6926836B2 · Fidoe et al. · 2005 [cited by applicant]
US 9919348B2 · Peng et al. · 2018 [cited by applicant]
US 10113102B2 · Peng et al. · 2018 [cited by applicant]
US 11208589B2 · Shen et al. · 2021 [cited by applicant]
US 11421143B2 · Mahmoud et al. · 2022 [cited by applicant]
US 11560774B2 · Chen et al. · 2023 [cited by applicant]
US 11584878B1 · Yue et al. · 2023 [cited by applicant]
US 11584879B1 · Mosina et al. · 2023 [cited by applicant]
US 20050067164A1 · Ke · 2005 [cited by examiner]
US 20120168364A1 · Evans · 2012 [cited by applicant]
US 20170355895A1 · Peng · 2017 [cited by examiner]
US 20180112124A1 · Conner et al. · 2018 [cited by applicant]
US 20180148632A1 · Bennett et al. · 2018 [cited by applicant]
US 20180347316A1 · Peng et al. · 2018 [cited by applicant]
US 20210207019A1 · Elkatatny et al. · 2021 [cited by applicant]
US 20210246354A1 · Rodgers et al. · 2021 [cited by applicant]
US 20210395123A1 · Labarre et al. · 2021 [cited by applicant]
US 20220056331A1 · Griffin · 2022 [cited by applicant]
US 20230133492A1 · Mosina et al. · 2023 [cited by applicant]
US 20230183554A1 · Bennett et al. · 2023 [cited by applicant]
US 20230193113A1 · Mosina et al. · 2023 [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2023/032759 dated May 22, 2024. PDF file. 7 pages. [cited by applicant]
Solvay, Solvay Novecare Launches FeSOLV scale control technology to treat iron sulfide solids in oil and gas operations, 2015. [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2024/043078 dated Dec. 12, 2024. PDF file. 8 pages. [cited by applicant]
Cited By (1)
US 12,571,110